Rezolute (RZLT) Share-based Compensation (2010 - 2026)
Rezolute (RZLT) posted Share-based Compensation of $4.4 million for Q1 2026, up 29.58% sequentially from $3.4 million in Q4 2025, and up 132.02% YoY from $1.9 million in Q1 2025.
Rezolute (RZLT) Share-based Compensation (2010 - 2026) Analysis & Trends
Rezolute has reported Share-based Compensation for 16 years, with the latest figure at $4.4 million in Q1 2026.
- Quarterly Share-based Compensation rose 132.02% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 2.97% YoY) and the FY2025 annual result came in at $18.7 million, up 61.21% from the prior year.
- Share-based Compensation grew to $4.4 million in Q1 2026 per RZLT's latest filing, from $3.4 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $16.2 million in Q3 2025 and troughed at -$3.3 million in Q2 2023.
- A 5-year average of $2.8 million and a median of $1.9 million in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation plunged 3361.0% in 2023, then soared 1057.14% in 2025.
- Over 5 years, Share-based Compensation stood at $1.7 million in 2022, then rose by 6.12% to $1.8 million in 2023, then slipped by 21.34% to $1.4 million in 2024, then jumped by 136.06% to $3.4 million in 2025, then grew by 29.58% to $4.4 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $4.4 million, $3.4 million, and $16.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 4.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.42 Mn |
| Mar 31, 2026 | 4.42 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 16.20 Mn |
| Sep 30, 2025 | 16.20 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 7.01 Mn |
| Jun 30, 2024 | 7.01 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Dec 31, 2023 | 1.84 Mn |